High baseline levels of inflammatory cytokines linked to thrombotic events in patients with COVID-19

By | June 7, 2021
In a recent open-access paper published in the Journal of Clinical Medicine, researchers from Iran and Germany show that high baseline levels of inflammatory cytokines measured during admission put patients with coronavirus disease (COVID-19) at increased risk of developing coagulopathy, thrombotic events – and even death.